Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1998
03/19/1998WO1998011110A1 3-substituted pyrido[4',3':4,5]thieno[2,3-d]pyrimidine derivatives, their preparation and their use
03/19/1998WO1998011109A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
03/19/1998WO1998011108A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
03/19/1998WO1998011106A1 Tricyclic compounds useful as fpt inhibitors
03/19/1998WO1998011104A1 Heterocyclic compounds and their use for isolating nucleic acids
03/19/1998WO1998011101A2 Condensed n-aclyindoles as antitumor agents
03/19/1998WO1998011100A1 Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase
03/19/1998WO1998011099A1 Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase
03/19/1998WO1998011098A1 Novel tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
03/19/1998WO1998011097A1 Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase
03/19/1998WO1998011096A1 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
03/19/1998WO1998011095A1 Substituted 2-pyrimidineamines, their preparation and their use as proteine kinase inhibitors
03/19/1998WO1998011094A1 Benzamidine derivatives substituted by cyclic amino acid or cycl ic hydroxy acid derivatives and their use as anti-coagulants
03/19/1998WO1998011093A1 Tricyclic inhibitors of farnesyl protein transferase
03/19/1998WO1998011092A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
03/19/1998WO1998011091A2 Tricyclic compounds useful for inhibition of farnesyl protein transferase
03/19/1998WO1998011089A1 Novel benzothiophene derivatives, their preparation and use as urokinase inhibitors
03/19/1998WO1998011086A1 Chromone derivatives and nerve cell death inhibitors containing the same
03/19/1998WO1998011075A1 Pyrazinones and triazinones and their derivatives thereof
03/19/1998WO1998011073A1 8-hydroxy-7-substituted quinolines as anti-viral agents
03/19/1998WO1998011068A1 D4 receptor selectivity piperazine derivatives
03/19/1998WO1998011067A1 Preparation of 1-butyl-4-piperidinylmethylamine
03/19/1998WO1998011066A1 Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications
03/19/1998WO1998011063A1 Cytostatic hydroxamic acid derivatives
03/19/1998WO1998011062A1 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
03/19/1998WO1998011049A1 Lipoxin compounds and their use in treating cell proliferative disorders
03/19/1998WO1998010798A1 Improved methods for diagnostic imaging using a contrast agent and a vasodilator
03/19/1998WO1998010795A2 Tumor homing molecules, conjugates derived therefrom, and methods of using same
03/19/1998WO1998010793A1 Formulations for topical use
03/19/1998WO1998010786A2 Pharmaceutical composition for the treatment of syndrome x of reaven
03/19/1998WO1998010782A1 Antifungal combination therapy
03/19/1998WO1998010781A1 Means for treating prostate hypertrophy and prostate cancer
03/19/1998WO1998010779A1 Method for treating parasitic diseases with proteasome inhibitors
03/19/1998WO1998010773A1 Pharmaceutical compositions with antimicrobial activity
03/19/1998WO1998010772A1 Method for inhibiting desoxyribonucleotide triphosphate biosynthesis
03/19/1998WO1998010771A1 Prevention of ovarian cancer by administration of progestin products
03/19/1998WO1998010770A1 Oral compositions containing fluocinonide
03/19/1998WO1998010769A1 Formulations and methods for providing prolonged local anesthesia
03/19/1998WO1998010768A1 Antiviral compositions
03/19/1998WO1998010767A2 Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
03/19/1998WO1998010766A1 METHOD OF INHIBITING BIOSYNTHESIS OF EIf5A
03/19/1998WO1998010765A1 Non-hormonal method of contraception
03/19/1998WO1998010764A1 Pharmaceutical composition for treating viral diseases
03/19/1998WO1998010763A1 Thrombin inhibitors
03/19/1998WO1998010762A2 Controlled release dosage form of r-(z)-alpha-methoxyimino-alpha-(1-azabicyclo2.2oct-c-yl)acetonitrile monohydrochloride
03/19/1998WO1998010761A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
03/19/1998WO1998010760A1 Glutathione reductase activity potentiator containing troglitazone
03/19/1998WO1998010759A1 Method of producing analgesia
03/19/1998WO1998010758A1 Methods for treatment of retinal diseases
03/19/1998WO1998010757A2 The use of functional n-methyl-d-aspartate antagonists to ameliorate or prevent aminoglycoside-induced ototoxicity
03/19/1998WO1998010754A1 Fast decomposing pellets
03/19/1998WO1998010753A1 Captopril tablets
03/19/1998WO1998010750A2 Nucleic acid particle delivery
03/19/1998WO1998010747A1 Immunomodulatory formulation
03/19/1998WO1998010744A1 Composition comprising an antiviral or antibacterial agent for preventing transmission of diseases
03/19/1998WO1998010742A1 Composition base for topical therapeutic and cosmetic preparations
03/19/1998WO1998010739A1 Topical composition and method for enhancing lipid barrier synthesis
03/19/1998WO1998010652A1 NOVEL trpS
03/19/1998WO1998010650A1 Method of treating endothelial injury
03/19/1998WO1998010647A1 Topical preparation of diphenhydramine and hydrocortisone to treat dermatitis
03/19/1998WO1998006387A3 Oral composition comprising 5-aminosalicylic acid
03/19/1998WO1998006265A3 Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound, especially n-dodecyl-morpholine
03/19/1998WO1998004289A3 Pharmaceutical composition containing a 5ht2c antagonist and a d2 antagonist
03/19/1998WO1998003178A3 Pharmaceutical compositions containing p2y purinergic receptor antagonists
03/19/1998WO1998003156A3 Topically applied composition for hormone replacement therapy
03/19/1998WO1998001099A3 Method of treating retinal ischemia and glaucoma
03/19/1998WO1997042975A3 Chitosan related compositions for delivery of nucleic acids into a cell
03/19/1998DE19638045A1 Injektionsformulierungen von Avermectinen und Milbemycinen Injection formulations of avermectins and milbemycins
03/19/1998DE19637237A1 Piperazin-Derivate Piperazine derivatives
03/19/1998DE19637123A1 Neue Pyranosidderivate New Pyranosidderivate
03/19/1998DE19637082A1 Schnellzerfallende Pellets Rapidly disintegrating pellets
03/19/1998DE19637042A1 Heterocyclische Verbindungen und deren Verwendung in der Detektion von Nucleinsäuren Heterocyclic compounds and their use in the detection of nucleic acids
03/19/1998CA2698393A1 Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (hnf) 1 alpha (.alpha.), hnf-1.beta. and hnf-4.alpha.
03/19/1998CA2266469A1 Method of producing analgesia
03/19/1998CA2266051A1 3-substituted-d-homo-1,3,5,(10)-estratriene derivatives
03/19/1998CA2266028A1 Oral compositions containing fluocinonide
03/19/1998CA2266014A1 Tricyclic compounds useful for inhibition of farnesyl protein transferase
03/19/1998CA2265887A1 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof
03/19/1998CA2265877A1 Polydithiocarbamate-containing macromolecules and the use thereof for therapeutic and diagnostic applications
03/19/1998CA2265764A1 Tricyclic compounds useful as fpt inhibitors
03/19/1998CA2265763A1 Tricyclic piperidinyl compounds useful as inhibitors of farnesyl-protein transferase
03/19/1998CA2265727A1 Heterocyclic compounds and their use for isolating nucleic acids
03/19/1998CA2265697A1 Prevention of ovarian cancer by administration of progestin products
03/19/1998CA2265661A1 Controlled release dosage form of r-(z)-alpha-methoxyimino-alpha-(1-azabicyclo2.2.2oct-c-yl)acetonitrile monohydrochloride
03/19/1998CA2265656A1 Glutathione reductase activity potentiator containing troglitazone
03/19/1998CA2265630A1 Use of quinazoline derivatives for the manufacture of a medicament in the treatment of hyperproliferative skin disorders
03/19/1998CA2265561A1 Formulations and methods for providing prolonged local anesthesia
03/19/1998CA2265542A1 Pharmaceutical composition for treating viral diseases
03/19/1998CA2265509A1 3-substituted pyrido(4',3':4,5)thieno(2,3-d)pyrimidine derivatives, their preparation and their use
03/19/1998CA2265495A1 Non-hormonal method of contraception
03/19/1998CA2265467A1 Ptx sensitive g proteins, the production and use thereof
03/19/1998CA2264829A1 Materials and methods relating to the diagnosis and treatment of diabetes and obesity
03/19/1998CA2264666A1 Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase
03/19/1998CA2264605A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
03/19/1998CA2264521A1 Benzamidine derivatives substituted by cyclic amino acid or cyclic hydroxy acid derivatives and their use as anti-coagulants
03/19/1998CA2264147A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
03/19/1998CA2264037A1 Thrombin inhibitors
03/19/1998CA2262818A1 Modified amino acids, pharmaceuticals containing these compounds and methods for their production
03/19/1998CA2262786A1 8-hydroxy-7-substituted quinolines as anti-viral agents
03/19/1998CA2259283A1 Method for treating amyotrophic lateral sclerosis
1 ... 6677 6678 6679 6680 6681 6682 6683 6684 6685 6686 6687 6688 6689 6690 6691 6692 6693 6694 6695 6696 6697 ... 7860